FI830617L - 1,4-dihydropyridin-derivat, deras framstaellning och dessa innehaollande farmaceutiksa produkter - Google Patents

1,4-dihydropyridin-derivat, deras framstaellning och dessa innehaollande farmaceutiksa produkter

Info

Publication number
FI830617L
FI830617L FI830617A FI830617A FI830617L FI 830617 L FI830617 L FI 830617L FI 830617 A FI830617 A FI 830617A FI 830617 A FI830617 A FI 830617A FI 830617 L FI830617 L FI 830617L
Authority
FI
Finland
Prior art keywords
dihydropyridine derivatives
deras framstaellning
framstaellning och
dessa innehaollande
och dessa
Prior art date
Application number
FI830617A
Other languages
English (en)
Finnish (fi)
Other versions
FI830617A0 (fi
Inventor
Arnold Vogel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI830617A0 publication Critical patent/FI830617A0/fi
Publication of FI830617L publication Critical patent/FI830617L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI830617A 1982-03-10 1983-02-24 1,4-dihydropyridin-derivat, deras framstaellning och dessa innehaollande farmaceutiksa produkter FI830617L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH147782 1982-03-10

Publications (2)

Publication Number Publication Date
FI830617A0 FI830617A0 (fi) 1983-02-24
FI830617L true FI830617L (fi) 1983-09-11

Family

ID=4211396

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830617A FI830617L (fi) 1982-03-10 1983-02-24 1,4-dihydropyridin-derivat, deras framstaellning och dessa innehaollande farmaceutiksa produkter

Country Status (17)

Country Link
JP (1) JPS58180483A (xx)
AU (1) AU1169583A (xx)
BE (1) BE895957A (xx)
CH (1) CH660190A5 (xx)
DE (1) DE3305577A1 (xx)
DK (1) DK63583A (xx)
ES (1) ES520201A0 (xx)
FI (1) FI830617L (xx)
FR (1) FR2523128B1 (xx)
GB (1) GB2117761B (xx)
IL (1) IL68005A0 (xx)
IT (1) IT1197588B (xx)
NL (1) NL8300739A (xx)
PT (1) PT76290B (xx)
SE (1) SE8301072L (xx)
WO (1) WO1983003097A1 (xx)
ZA (1) ZA83959B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
JP2002202369A (ja) * 2000-12-27 2002-07-19 Nikon Corp 光信号検出装置及び測距装置
CN102766137B (zh) * 2012-08-07 2015-07-08 四川百利药业有限责任公司 一种高纯度伊拉地平的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
FI793848A (fi) * 1978-12-18 1980-06-19 Sandoz Ag Benzoxadiazoler och benzothiadiazoler deras framstaellning och farmaceutiska kompositioner innehaollande dessa
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
GB2050375B (en) * 1979-05-11 1983-02-23 Fujisawa Pharmaceutical Co 4-cyanophenyl-1,4-dihydropyridine compound processes for preparation thereof and pharmaceutical composition comprising the same
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals

Also Published As

Publication number Publication date
IT1197588B (it) 1988-12-06
FR2523128A1 (fr) 1983-09-16
PT76290A (en) 1983-03-01
GB2117761A (en) 1983-10-19
DK63583D0 (da) 1983-02-14
ES8500057A1 (es) 1984-10-01
GB2117761B (en) 1986-01-29
AU1169583A (en) 1983-09-15
SE8301072D0 (sv) 1983-02-25
DK63583A (da) 1983-09-11
NL8300739A (nl) 1983-10-03
CH660190A5 (de) 1987-03-31
IT8347806A0 (it) 1983-02-25
PT76290B (en) 1985-12-03
GB8305525D0 (en) 1983-03-30
SE8301072L (sv) 1983-09-11
JPS58180483A (ja) 1983-10-21
ZA83959B (en) 1984-09-26
FI830617A0 (fi) 1983-02-24
IL68005A0 (en) 1983-06-15
FR2523128B1 (fr) 1985-10-18
BE895957A (fr) 1983-08-22
DE3305577A1 (de) 1983-09-22
ES520201A0 (es) 1984-10-01
WO1983003097A1 (en) 1983-09-15

Similar Documents

Publication Publication Date Title
FI842395A0 (fi) 13 -alkylgonaner, deras framstaellning och dessa innehaollande farmaceutiska produkter.
FI822005L (fi) Antifungisida aemnen, foerfarande foer deras framstaellning, och dessa innehaollande farmaceutiska sammansaettningar
FI821123L (fi) Lokalt anvaendbara farmaceutiska produkter
FI810558L (fi) 2(1h)-pyridinonderivat deras framstaellning och dessa innehaollande farmaceutiska produkter
FI823544L (fi) Triazinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar
FI850455A0 (fi) Farmaceutiska produkter.
FI862590A0 (fi) Farmaceutiska produkter.
FI813412L (fi) 3-aminopropoxifenylderivat deras framstaellning och dessa innehaollande farmaceutiska produkter
FI831619L (fi) 2(1h)-pyridinonderivat, deras framstaellning och dessa innehaollande farmaceutiska produkter
FI881474A (fi) Foerfarande foer framstaellning av en sprutad yta av definierad grovhet och tillaempning av foerfarandet.
FI853199L (fi) Farmaceutiska sammansaettningar med tumoermotverkande effekt och foerfarande foer framstaellning av dessa.
DK299784D0 (da) 1,4-dihydropyridinderivater
FI844153L (fi) 1,2-ditiolanderivat, deras framstaellningsfoerfarande, dessa innehaollande farmaceutiska produkter och deras anvaendning.
FI863382A (fi) Substituerade toluidiner, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning foer haemmande av magsyrasekretion.
FI810934L (fi) Farmaceutiska produkter
DK267781A (da) 2,3-bis-hydroxybenzylderivater
FI830617A0 (fi) 1,4-dihydropyridin-derivat, deras framstaellning och dessa innehaollande farmaceutiksa produkter
DE3371781D1 (de) 1,4-methano-2-benzazepine derivatives
FI803846L (fi) Farmaceutiska produkter
FI830399A0 (fi) Mjoeldryge-alkaloider, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
DE3469732D1 (de) 3,5-dialkyl-4-hydroxyphenyl-substituted derivatives
FI822980A0 (fi) Furanokromonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
DK179984A (da) 1,4-dihydropyridinderivater
FI823694A0 (fi) N-substituerade ergolin- och 9,10,-didehydro-ergolin-8-karboxiamid-8-aminometyl-derivat, deras framstaellning och deras farmaceutiska komposition
DE3363710D1 (de) 1,3,5-triacrylylhexahydro-s-triazine derivatives

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG